Infographic
Single Drug Assessments in Lung Cancer
Published SDA in Lung Cancer 2011 - July 2022
Aug 04, 2022
Download

The Health Technology Assessment (HTA) Accelerator from IQVIA lets you analyze past and current payer assessments and evidence requirements to guide clinical trial design and market access strategy across the product lifecycle. Analyze the numbers of Single drug assessments in Lung cancer from January 2011 till July 2022. If you need more detailed analysis, request your trial access: https://www.iqvia.com/form-pages/demo

Related solutions

Contact Us